Published March 30, 2022
| Version v1
Report
Open
Modelled public health impact and cost effectiveness estimates of RTS,S/AS01 malaria vaccine in perennial and seasonal settings (August 2021)
Description
Reports considered by the Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) for the development of the malaria vaccine recommendation, “Section 4.3 Vaccine” of the WHO Guidelines for malaria, originally published 18 February 2022.
Files
Modelled-public-health-impact-and-cost-effectiveness-rtss-vaccine-2021.pdf
Files
(3.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:7399ec680c7f45a58345054d7fb5d6cc
|
3.0 MB | Preview Download |